Activation of cytotoxic T lymphocytes by self-differentiated myeloid-derived dendritic cells for killing breast cancer cells expressing folate receptor alpha protein.
Adoptive cell transfer
SmartDC
breast cancer
cytotoxic T lymphocytes
folate receptor alpha
Journal
Bioengineered
ISSN: 2165-5987
Titre abrégé: Bioengineered
Pays: United States
ID NLM: 101581063
Informations de publication
Date de publication:
06 2022
06 2022
Historique:
entrez:
23
6
2022
pubmed:
24
6
2022
medline:
25
6
2022
Statut:
ppublish
Résumé
Adoptive cell transfer (ACT) is a promising approach for cancer treatment. Activation of T lymphocytes by
Identifiants
pubmed: 35734827
doi: 10.1080/21655979.2022.2084262
pmc: PMC9342379
doi:
Substances chimiques
Folate Receptor 1
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
14188-14203Références
Nat Rev Immunol. 2020 Jan;20(1):7-24
pubmed: 31467405
J Immunol. 2008 Dec 15;181(12):8576-84
pubmed: 19050277
Nat Commun. 2019 Dec 4;10(1):5531
pubmed: 31797935
Ther Adv Med Oncol. 2020 Jun 30;12:1758835920936151
pubmed: 32655700
Immunotherapy. 2017 Jun;9(7):589-606
pubmed: 28595516
Int J Cancer. 2006 Jul 15;119(2):243-50
pubmed: 16453285
Cancer Immunol Immunother. 2008 Feb;57(2):271-80
pubmed: 17646988
Ann Transl Med. 2020 Jul;8(14):907
pubmed: 32793751
Bioengineered. 2020 Dec;11(1):1280-1300
pubmed: 33164640
Clin Adv Hematol Oncol. 2016 Nov;14(11):922-933
pubmed: 27930644
Clin Cancer Res. 2018 Jul 1;24(13):3014-3025
pubmed: 29545464
Surg Oncol Clin N Am. 2018 Jan;27(1):95-120
pubmed: 29132568
J Clin Oncol. 2006 Sep 10;24(26):4254-61
pubmed: 16908932
Cancer Res. 2006 Jul 1;66(13):6826-33
pubmed: 16818660
Cell Death Dis. 2017 Jun 1;8(6):e2836
pubmed: 28569770
Springerplus. 2012 Sep 28;1:22
pubmed: 23961352
Gene Ther. 2015 Sep;22(9):707-20
pubmed: 25965393
Sci Rep. 2017 May 19;7(1):2193
pubmed: 28526819
Trends Immunol. 2019 Apr;40(4):292-309
pubmed: 30871979
Front Pharmacol. 2018 Jun 26;9:642
pubmed: 29997500
Immunol Rev. 2010 Jul;236:151-66
pubmed: 20636815
PLoS One. 2015 Mar 27;10(3):e0122209
pubmed: 25816016
Front Immunol. 2017 Mar 27;8:327
pubmed: 28396662
Assay Drug Dev Technol. 2014 May;12(4):207-18
pubmed: 24831787
Biomark Res. 2020 Sep 29;8:49
pubmed: 33005420
Cancer Immunol Immunother. 2018 Oct;67(10):1579-1588
pubmed: 30056600
Gene Ther. 2011 Aug;18(8):750-64
pubmed: 21412283
Hum Gene Ther. 2013 Feb;24(2):220-37
pubmed: 23311414
Anticancer Res. 1999 Jul-Aug;19(4B):2907-16
pubmed: 10652572
Cancer Res. 1990 Sep 15;50(18):6075-86
pubmed: 1975513
Oncoimmunology. 2014 Aug 03;3(8):e954893
pubmed: 25960936
Science. 1988 May 27;240(4856):1169-76
pubmed: 3131876
PLoS One. 2016 Nov 17;11(11):e0166280
pubmed: 27855183
Bioengineered. 2017 Jul 4;8(4):367-373
pubmed: 27754760
Semin Immunol. 2009 Oct;21(5):265-72
pubmed: 19524453
Nucleic Acids Res. 2001 May 1;29(9):e45
pubmed: 11328886
Cell J. 2013 Fall;15(3):218-23
pubmed: 24027662
Front Biosci. 2006 Jan 01;11:506-19
pubmed: 16146749
Clin Breast Cancer. 2017 Nov;17(7):544-549
pubmed: 28410844
Breast Cancer (Auckl). 2020 Apr 29;14:1178223420906428
pubmed: 32425539
Arch Pathol Lab Med. 2014 Jul;138(7):890-5
pubmed: 24028341
Nat Rev Clin Oncol. 2020 Jun;17(6):349-359
pubmed: 32152484
Breast Cancer Res. 2013 Oct 01;15(5):R92
pubmed: 24286369
Breast Cancer Res. 2004;6(4):R322-8
pubmed: 15217499
J Carcinog. 2019 May 23;18:2
pubmed: 31160888
NPJ Breast Cancer. 2020 Feb 4;6:4
pubmed: 32047850
Hum Gene Ther Methods. 2012 Feb;23(1):38-55
pubmed: 22428979
Cancers (Basel). 2020 Aug 24;12(9):
pubmed: 32846967
Breast Cancer Res Treat. 2021 Feb;186(1):25-36
pubmed: 33389403
BMC Biotechnol. 2013 Nov 12;13:98
pubmed: 24215295
Breast Cancer (Dove Med Press). 2019 Apr 10;11:151-164
pubmed: 31040712
PLoS One. 2010 Jul 29;5(7):e11867
pubmed: 20686618